Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.88M | $0.00 | -$30.62M | -$35.84M | -$5.66 | N/A | -100.00% | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $32.98M | $5.26M | -$16.33M | -$20.58M | -$1.70 | -8.16% | 28.67% | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $19.04M | $0.00 | -$17.74M | -$18.50M | -$0.48 | N/A | N/A | N/A | N/A | |||
| NRXP | NRX PHARMACEUTICALS INC | $62.94M | $242.00k | -$38.02M | -$38.06M | -$2.36 | N/A | N/A | N/A | N/A | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $395.01M | $0.00 | -$227.85M | -$240.91M | -$2.25 | N/A | N/A | N/A | N/A | 2026-03-02 | ||
| SGMO | SANGAMO THERAPEUTICS INC | $127.53M | $32.88M | -$101.50M | -$108.91M | -$0.45 | -37.13% | -25.91% | N/A | N/A | 2026-02-25 | ||
| SKYE | SKYE BIOSCIENCE INC | $34.30M | $0.00 | -$50.55M | -$51.23M | -$1.29 | N/A | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $51.06M | $0.00 | -$18.04M | -$20.26M | -$0.82 | N/A | N/A | N/A | N/A | |||
| TLRY | TILRAY BRANDS INC | $980.99M | $837.32M | -$2.11B | -$2.11B | -$23.11 | 0.98% | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $34.80M | $2.06M | -$17.01M | -$19.80M | -$0.72 | 63.53% | N/A | N/A | N/A | |||
| NAKA | KINDLY MD INC | $171.98M | $1.98M | -$89.61M | -$90.49M | -$1.11 | -31.13% | N/A | N/A | N/A | 2026-02-13 | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $29.15M | $0.00 | -$14.51M | -$12.70M | -$0.55 | N/A | N/A | N/A | N/A | 2026-02-25 | ||
| SLN | SILENCE THERAPEUTICS PLC | $241.12M | $26.10M | -$67.75M | -$66.59M | N/A | 27.31% | N/A | N/A | N/A | 2026-03-18 | ||
| ACET | ADICET BIO INC | $81.80M | $0.00 | -$105.29M | -$115.01M | -$20.00 | N/A | -100.00% | N/A | N/A | 2026-03-05 | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $34.86M | $0.00 | -$22.71M | -$22.76M | -$0.46 | N/A | N/A | N/A | N/A | 2026-03-23 | ||
| IFRX | INFLARX NV | $65.51M | $73.07k | -$46.08M | -$46.63M | -$0.70 | -60.51% | N/A | N/A | N/A | 2026-03-19 | ||
| IMUX | IMMUNIC INC | $74.82M | $0.00 | -$102.73M | -$103.05M | -$0.83 | N/A | N/A | N/A | N/A | 2026-02-19 | ||
| PDSB | PDS BIOTECHNOLOGY CORP | $44.03M | $0.00 | -$32.21M | -$34.88M | -$0.82 | N/A | N/A | N/A | N/A | 2026-03-26 | ||
| SNTI | SENTI BIOSCIENCES INC | $27.87M | $0.00 | -$43.38M | -$47.58M | -$3.28 | N/A | N/A | N/A | N/A | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $5.20M | $11.57M | -$10.72M | -$15.86M | -$303.00 | -48.05% | 49.54% | N/A | N/A | 2026-03-26 | ||
| ATYR | ATYR PHARMA INC | $69.28M | $190.00k | -$73.96M | -$75.12M | -$0.82 | -19.15% | -53.29% | N/A | N/A | 2026-03-12 | ||
| TVRD | TVARDI THERAPEUTICS INC | $40.43M | $4.02M | -$8.73M | -$13.95M | -$8.50 | -21.70% | -31.91% | N/A | N/A | 2026-03-11 | ||
| VNRX | VOLITIONRX LTD | $32.79M | $1.47M | -$21.14M | -$22.88M | -$0.23 | 14.48% | 197.53% | N/A | N/A | |||
| VERU | VERU INC | $43.01M | $0.00 | -$22.57M | -$22.73M | -$1.55 | N/A | -100.00% | N/A | N/A | |||
| HUMA | HUMACYTE INC | $192.89M | $1.57M | -$18.88M | -$36.97M | -$0.23 | N/A | N/A | N/A | N/A | 2026-03-26 | ||
| PALI | PALISADE BIO INC | $269.70M | $0.00 | -$11.10M | -$11.23M | -$2.12 | N/A | -100.00% | N/A | N/A | |||
| MYO | MYOMO INC | $36.13M | $41.64M | -$9.73M | -$12.02M | -$0.28 | 64.99% | 50.95% | N/A | N/A | 2026-03-16 | ||
| CTSO | CYTOSORBENTS CORP | $42.52M | $34.35M | -$8.52M | -$10.59M | -$0.18 | 15.09% | -1.19% | N/A | N/A | |||
| TNYA | TENAYA THERAPEUTICS INC | $116.22M | $0.00 | -$82.99M | -$94.26M | -$0.77 | N/A | N/A | N/A | N/A | 2026-03-24 | ||
| ZSPC | ZSPACE INC | $15.25M | $31.55M | -$20.08M | -$21.79M | -$135.53 | -24.20% | N/A | N/A | N/A | 2026-03-26 | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $167.69M | $1.20M | -$21.76M | -$28.32M | -$0.79 | N/A | N/A | N/A | N/A | |||
| ONCY | ONCOLYTICS BIOTECH INC | $120.22M | $0.00 | -$25.02M | -$25.19M | -$0.28 | N/A | N/A | N/A | N/A | 2026-03-05 | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $32.57M | $0.00 | -$65.24M | -$72.84M | -$1.62 | -100.00% | N/A | N/A | N/A | 2026-03-19 | ||
| IOBT | IO BIOTECH INC | $23.67M | $0.00 | -$87.26M | -$88.35M | -$1.35 | N/A | N/A | N/A | N/A | 2026-03-04 | ||
| JSPR | JASPER THERAPEUTICS INC | $45.89M | $0.00 | -$89.05M | -$91.02M | -$5.92 | N/A | N/A | N/A | N/A | |||
| HELP | CYBIN INC | $166.99M | $0.00 | -$70.85M | -$71.04M | -$3.20 | N/A | N/A | N/A | N/A | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.95M | $0.00 | -$29.28M | -$29.28M | -$18.90 | N/A | N/A | N/A | N/A | |||
| MREO | MEREO BIOPHARMA GROUP PLC | $75.11M | $500.00k | -$42.09M | -$41.57M | -$0.30 | -50.00% | N/A | N/A | N/A | |||
| CLNN | CLENE INC | $53.63M | $214.00k | -$25.96M | -$30.50M | -$3.39 | -49.17% | 3.87% | N/A | N/A | |||
| KRRO | KORRO BIO INC | $101.14M | $7.37M | -$82.74M | -$88.42M | -$9.41 | N/A | -25.32% | N/A | N/A | |||
| BMEA | BIOMEA FUSION INC | $91.91M | $0.00 | -$91.46M | -$95.71M | -$2.38 | N/A | N/A | N/A | N/A | |||
| CING | CINGULATE INC | $39.80M | $0.00 | -$21.49M | -$22.06M | -$3.62 | N/A | N/A | N/A | N/A | |||
| INTZ | INTRUSION INC | $23.72M | $7.29M | -$6.25M | -$8.19M | -$0.45 | 33.49% | -0.86% | N/A | N/A | |||
| MGX | METAGENOMI INC | $62.33M | $30.91M | -$79.41M | -$88.74M | -$2.40 | -43.88% | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.